vs
百利高（PRGO）与RANGE RESOURCES CORP（RRC）财务数据对比。点击上方公司名可切换其他公司
百利高的季度营收约是RANGE RESOURCES CORP的1.4倍（$1.1B vs $786.9M），RANGE RESOURCES CORP净利率更高（22.8% vs -127.8%，领先150.6%），RANGE RESOURCES CORP同比增速更快（18.0% vs -2.5%），过去两年RANGE RESOURCES CORP的营收复合增速更高（14.6% vs 1.3%）
百利高（Perrigo）是一家注册于爱尔兰的非处方仿制药生产商，主打自有品牌OTC药品业务。公司70%的净销售额来自美国医疗市场，为优化税务布局将法定总部设在爱尔兰，该地区销售额仅占总营收的0.6%，2013年曾完成美国历史上第六大企业税收倒置交易。
Range Resources Corporation是一家总部位于美国得克萨斯州沃斯堡的天然气勘探开采企业，核心运营区域为马塞勒斯页岩地层，是该地区拥有土地面积最大的运营商，专注于天然气资源的勘探、开发与生产业务，在北美油气开发领域具备深厚的行业积累。
PRGO vs RRC — 直观对比
营收规模更大
PRGO
是对方的1.4倍
$786.9M
营收增速更快
RRC
高出20.5%
-2.5%
净利率更高
RRC
高出150.6%
-127.8%
两年增速更快
RRC
近两年复合增速
1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $786.9M |
| 净利润 | $-1.4B | $179.1M |
| 毛利率 | 32.6% | 94.5% |
| 营业利润率 | -116.0% | — |
| 净利率 | -127.8% | 22.8% |
| 营收同比 | -2.5% | 18.0% |
| 净利润同比 | -3093.9% | 88.8% |
| 每股收益（稀释后） | $-10.23 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRGORRC
| Q4 25 | $1.1B | $786.9M | ||
| Q3 25 | $1.0B | $655.3M | ||
| Q2 25 | $1.1B | $699.6M | ||
| Q1 25 | $1.0B | $846.3M | ||
| Q4 24 | $1.1B | $667.0M | ||
| Q3 24 | $1.1B | $567.9M | ||
| Q2 24 | $1.1B | $513.2M | ||
| Q1 24 | $1.1B | $598.8M |
净利润PRGORRC
| Q4 25 | $-1.4B | $179.1M | ||
| Q3 25 | $7.5M | $144.3M | ||
| Q2 25 | $-8.4M | $237.6M | ||
| Q1 25 | $-6.4M | $97.1M | ||
| Q4 24 | $-44.4M | $94.8M | ||
| Q3 24 | $-21.0M | $50.7M | ||
| Q2 24 | $-108.4M | $28.7M | ||
| Q1 24 | $2.0M | $92.1M |
毛利率PRGORRC
| Q4 25 | 32.6% | 94.5% | ||
| Q3 25 | 36.1% | 92.5% | ||
| Q2 25 | 34.4% | 95.0% | ||
| Q1 25 | 37.6% | 93.1% | ||
| Q4 24 | 33.9% | 93.7% | ||
| Q3 24 | 37.2% | 94.3% | ||
| Q2 24 | 37.0% | 93.4% | ||
| Q1 24 | 33.1% | 94.7% |
营业利润率PRGORRC
| Q4 25 | -116.0% | — | ||
| Q3 25 | 7.0% | — | ||
| Q2 25 | 4.3% | — | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | 10.0% | — | ||
| Q3 24 | 7.4% | — | ||
| Q2 24 | -2.5% | — | ||
| Q1 24 | -5.1% | — |
净利率PRGORRC
| Q4 25 | -127.8% | 22.8% | ||
| Q3 25 | 0.7% | 22.0% | ||
| Q2 25 | -0.8% | 34.0% | ||
| Q1 25 | -0.6% | 11.5% | ||
| Q4 24 | -3.9% | 14.2% | ||
| Q3 24 | -1.9% | 8.9% | ||
| Q2 24 | -10.2% | 5.6% | ||
| Q1 24 | 0.2% | 15.4% |
每股收益（稀释后）PRGORRC
| Q4 25 | $-10.23 | $0.75 | ||
| Q3 25 | $0.05 | $0.60 | ||
| Q2 25 | $-0.06 | $0.99 | ||
| Q1 25 | $-0.05 | $0.40 | ||
| Q4 24 | $-0.32 | $0.38 | ||
| Q3 24 | $-0.15 | $0.21 | ||
| Q2 24 | $-0.79 | $0.12 | ||
| Q1 24 | $0.01 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $204.0K |
| 总债务越低越好 | — | $1.2B |
| 股东权益账面价值 | $2.9B | $4.3B |
| 总资产 | $8.5B | $7.4B |
| 负债/权益比越低杠杆越低 | — | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资PRGORRC
| Q4 25 | — | $204.0K | ||
| Q3 25 | $432.1M | $175.0K | ||
| Q2 25 | $454.2M | $134.0K | ||
| Q1 25 | $409.9M | $344.6M | ||
| Q4 24 | $558.8M | $304.5M | ||
| Q3 24 | $1.5B | $277.4M | ||
| Q2 24 | $542.8M | $251.1M | ||
| Q1 24 | $658.5M | $343.1M |
总债务PRGORRC
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B | ||
| Q1 24 | — | $1.8B |
股东权益PRGORRC
| Q4 25 | $2.9B | $4.3B | ||
| Q3 25 | $4.4B | $4.2B | ||
| Q2 25 | $4.5B | $4.1B | ||
| Q1 25 | $4.4B | $3.9B | ||
| Q4 24 | $4.3B | $3.9B | ||
| Q3 24 | $4.6B | $3.9B | ||
| Q2 24 | $4.5B | $3.9B | ||
| Q1 24 | $4.7B | $3.8B |
总资产PRGORRC
| Q4 25 | $8.5B | $7.4B | ||
| Q3 25 | $10.1B | $7.2B | ||
| Q2 25 | $10.1B | $7.1B | ||
| Q1 25 | $9.8B | $7.4B | ||
| Q4 24 | $9.6B | $7.3B | ||
| Q3 24 | $11.2B | $7.2B | ||
| Q2 24 | $10.4B | $7.3B | ||
| Q1 24 | $10.6B | $7.4B |
负债/权益比PRGORRC
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.29× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.44× | ||
| Q1 24 | — | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $175.4M | $257.5M |
| 自由现金流经营现金流 - 资本支出 | $148.6M | — |
| 自由现金流率自由现金流/营收 | 13.4% | — |
| 资本支出强度资本支出/营收 | 2.4% | — |
| 现金转化率经营现金流/净利润 | — | 1.44× |
| 过去12个月自由现金流最近4个季度 | $145.1M | — |
8季度趋势，按日历期对齐
经营现金流PRGORRC
| Q4 25 | $175.4M | $257.5M | ||
| Q3 25 | $51.7M | $247.5M | ||
| Q2 25 | $75.9M | $336.2M | ||
| Q1 25 | $-64.5M | $330.1M | ||
| Q4 24 | $312.6M | $217.9M | ||
| Q3 24 | $42.2M | $245.9M | ||
| Q2 24 | $9.5M | $148.8M | ||
| Q1 24 | $-1.4M | $331.9M |
自由现金流PRGORRC
| Q4 25 | $148.6M | — | ||
| Q3 25 | $29.8M | — | ||
| Q2 25 | $56.7M | — | ||
| Q1 25 | $-90.0M | — | ||
| Q4 24 | $274.9M | — | ||
| Q3 24 | $15.1M | — | ||
| Q2 24 | $-18.9M | — | ||
| Q1 24 | $-26.5M | — |
自由现金流率PRGORRC
| Q4 25 | 13.4% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 5.4% | — | ||
| Q1 25 | -8.6% | — | ||
| Q4 24 | 24.2% | — | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | -1.8% | — | ||
| Q1 24 | -2.4% | — |
资本支出强度PRGORRC
| Q4 25 | 2.4% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 2.3% | — |
现金转化率PRGORRC
| Q4 25 | — | 1.44× | ||
| Q3 25 | 6.89× | 1.72× | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | — | 3.40× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | — | 4.85× | ||
| Q2 24 | — | 5.18× | ||
| Q1 24 | -0.70× | 3.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
